Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate comp… Read more
Imeik Technology Development Co (300896) - Total Assets
Latest total assets as of September 2025: CN¥8.70 Billion CNY
Based on the latest financial reports, Imeik Technology Development Co (300896) holds total assets worth CN¥8.70 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Imeik Technology Development Co - Total Assets Trend (2014–2024)
This chart illustrates how Imeik Technology Development Co’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Imeik Technology Development Co - Asset Composition Analysis
Current Asset Composition (December 2024)
Imeik Technology Development Co's total assets of CN¥8.70 Billion consist of 60.5% current assets and 39.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 18.2% |
| Accounts Receivable | CN¥176.23 Million | 2.1% |
| Inventory | CN¥72.84 Million | 0.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥110.19 Million | 1.3% |
| Goodwill | CN¥278.24 Million | 3.3% |
Asset Composition Trend (2014–2024)
This chart illustrates how Imeik Technology Development Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Imeik Technology Development Co's current assets represent 60.5% of total assets in 2024, a decrease from 77.2% in 2014.
- Cash Position: Cash and equivalents constituted 18.2% of total assets in 2024, down from 30.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 8.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 3.3% of total assets.
Imeik Technology Development Co Competitors by Total Assets
Key competitors of Imeik Technology Development Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Imeik Technology Development Co - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Imeik Technology Development Co generates 0.36x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Imeik Technology Development Co generates $ 23.47 in net profit.
Imeik Technology Development Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.03 | 16.56 | 48.75 |
| Quick Ratio | 9.79 | 16.32 | 48.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.62 Billion | CN¥ 4.40 Billion | CN¥ 4.29 Billion |
Imeik Technology Development Co - Advanced Valuation Insights
This section examines the relationship between Imeik Technology Development Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.95 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | 21.7% |
| Total Assets | CN¥8.34 Billion |
| Market Capitalization | $2.32 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Imeik Technology Development Co's assets below their book value (0.28 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Imeik Technology Development Co's assets grew by 21.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Imeik Technology Development Co (2014–2024)
The table below shows the annual total assets of Imeik Technology Development Co from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥8.34 Billion | +21.72% |
| 2023-12-31 | CN¥6.85 Billion | +9.49% |
| 2022-12-31 | CN¥6.26 Billion | +18.87% |
| 2021-12-31 | CN¥5.26 Billion | +13.65% |
| 2020-12-31 | CN¥4.63 Billion | +522.97% |
| 2019-12-31 | CN¥743.65 Million | +60.40% |
| 2018-12-31 | CN¥463.61 Million | +16.95% |
| 2017-12-31 | CN¥396.41 Million | +26.30% |
| 2016-12-31 | CN¥313.86 Million | +81.79% |
| 2015-12-31 | CN¥172.64 Million | +63.97% |
| 2014-12-31 | CN¥105.29 Million | -- |